Autologous Stem Cell Transplant
Showing 51 - 75 of >10,000
Relapsed Diffuse Large B-cell Lymphoma Trial in Detroit (loncastuximab tesirine)
Recruiting
- Relapsed Diffuse Large B-cell Lymphoma
- loncastuximab tesirine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Jun 24, 2022
Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Pembrolizumab
- +2 more
-
Hackensack, New JerseyJohn Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,
Active, not recruiting
- Stage I Multiple Myeloma
- +2 more
- dexamethasone
- +4 more
-
Chicago, Illinois
- +4 more
Sep 3, 2022
Neuroblastoma Trial in Minneapolis (drug, biological, radiation)
Recruiting
- Neuroblastoma
- Carboplatin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Limbal Stem Cell Deficiency Trial in Boston (Biopsy to collect limbal epithelial stem cells that will be cultivated into a
Active, not recruiting
- Limbal Stem Cell Deficiency
- Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft
- +2 more
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Mar 21, 2022
Plasma Cell Myeloma Trial in Buffalo (Belantamab Mafodotin, Lenalidomide)
Recruiting
- Plasma Cell Myeloma
- Belantamab Mafodotin
- Lenalidomide
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 5, 2022
Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,
Active, not recruiting
- Plasma Cell Myeloma
- Transplant-Related Carcinoma
- Ixazomib Citrate
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Jul 12, 2022
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)
Completed
- Multiple Myeloma
- Thalidomide+Melphalan +Bortezomib+stem cell transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Haematopoietic Stem Cell Transplant, Autologous Trial in Melbourne,
Completed
- Acute Myeloid Leukemia
- +4 more
- FDG-PET/CT
- Conventional CT
-
Melbourne, Victoria, Australia
- +1 more
May 15, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
COVID-19 After Autologous Hematopoietic Stem Cell
Completed
- Covid19
- +4 more
- Autologous stem cell transplantation
-
Uppsala, SwedenUppsala Universitet
Feb 7, 2022
Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)
Recruiting
- Autologous Haematopoietic Stem Cell Transplant
- plerixafor + G-CSF
-
China, ChinaInvestigational Sites
May 4, 2022
Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)
Recruiting
- Transfusion Dependent Beta Thalassemia
- +3 more
- EDIT-301
-
Oakland, California
- +3 more
Jan 3, 2023
Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)
Recruiting
- Plasma Cell Myeloma
- Secondary Amyloidosis
- Autologous Hematopoietic Stem Cell Transplantation
- +3 more
-
Duarte, California
- +1 more
Dec 27, 2021
Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)
Recruiting
- Lymphoma
- +3 more
- Isatuximab
- Standard Procedures
-
New York, New YorkColumbia University
Apr 27, 2022
Lymphoma Trial in Duarte (drug, other, procedure)
Active, not recruiting
- Lymphoma
- carmustine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
